These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 7393997)

  • 21. [Valpromide-amitriptyline interaction. Increase in the bioavailability of amitriptyline and nortriptyline caused by valpromide].
    Bertschy G; Vandel S; Jounet JM; Allers G
    Encephale; 1990; 16(1):43-5. PubMed ID: 2109680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacological treatment of delusional depression: Part II.
    Spiker DG; Perel JM; Hanin I; Dealy RS; Griffin SJ; Soloff PH; Weiss JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):339-42. PubMed ID: 3805326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of low-dose amitriptyline in psychogeriatrics. A clinical, pharmacokinetic and pharmacogenetic study].
    Schnyder C; Baumann P; Jonzier-Perey M; Koeb L; Wertheimer J
    Schweiz Med Wochenschr; 1985 Aug; 115(33):1128-34. PubMed ID: 4035330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative double-blind controlled study of trimipramine and amitriptyline in major depression: lack of correlation with 5-hydroxytryptamine reuptake blockade.
    Cournoyer G; de Montigny C; Ouellette J; Langlois R; Elie R; Caille G; le Morvan P
    J Clin Psychopharmacol; 1987 Dec; 7(6):385-93. PubMed ID: 3323262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation of plasma levels and clinical response to amitriptyline in treating endogenous depression].
    Liu P
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):263-6, 318. PubMed ID: 3234157
    [No Abstract]   [Full Text] [Related]  

  • 26. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Zerbi F; Savoldi F
    Psychopharmacology (Berl); 1990; 100(3):334-8. PubMed ID: 2315430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum concentrations of amitriptyline and its metabolites and clinical effect in depressive patients].
    Zhang X
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Aug; 25(4):196-8, 252. PubMed ID: 1478132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amitriptyline and nortriptyline response profiles in unipolar depressed patients.
    Lehmann LS; Bowden CL; Redmond FC; Stanton BC
    Psychopharmacology (Berl); 1982; 77(2):193-7. PubMed ID: 6812139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a therapeutic plasma level range in amitriptyline treatment of depression.
    Breyer-Pfaff U; Giedke H; Gaertner HJ; Nill K
    J Clin Psychopharmacol; 1989 Apr; 9(2):116-21. PubMed ID: 2723128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A radioimmunoassay for the determination of combined amitriptyline and nortriptyline concentrations in microliter samples of plasma.
    Robinson JD; Risby D; Riley G; Aherne GW
    J Pharmacol Exp Ther; 1978 May; 205(2):499-502. PubMed ID: 641845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amitriptyline plasma levels and clinical response in primary depression.
    Kupfer DJ; Hanin I; Spiker DG; Grau T; Coble P
    Clin Pharmacol Ther; 1977 Dec; 22(6):904-11. PubMed ID: 923185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical trial comparing sustained release amitryptyline (Saroten Retard) and conventional amitriptyline tablets (Saroten) in endogenously depressed patients with simultaneous determination of serum levels of amitryptyline and nortriptyline.
    Liisberg P; Mose H; Amdisen A; Jørgensen A; Petersen HE
    Acta Psychiatr Scand; 1978 May; 57(5):426-35. PubMed ID: 354330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tricyclic plasma levels in depressed outpatients treated with amitriptyline.
    Rickels K; Weise C; Case G; Hucker H
    Psychopharmacology (Berl); 1983; 80(1):14-8. PubMed ID: 6408663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of tricyclic antidepressant therapy.
    Dawling S
    Clin Biochem; 1982 Feb; 15(1):56-61. PubMed ID: 7067078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison study of amitriptyline and nortriptyline with plasma levels.
    Ziegler VE; Clayton PJ; Biggs JT
    Arch Gen Psychiatry; 1977 May; 34(5):607-12. PubMed ID: 860894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels, psychophysiological variables, and clinical response to amitriptyline.
    Breyer-Pfaff U; Gaertner HJ; Giedke H
    Psychiatry Res; 1982 Apr; 6(2):223-34. PubMed ID: 6953461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amitriptyline and hydroxylated metabolite plasma levels in depressed outpatients.
    Robinson DS; Cooper TB; Howard D; Corcella J; Albright D
    J Clin Psychopharmacol; 1985 Apr; 5(2):83-8. PubMed ID: 3988974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality control of amitriptyline and nortriptyline plasma level assessments: a multicenter study.
    Baumann P; Breyer-Pfaff U; Kuss HJ; Müller-Oerlinghausen B; Sandoz M
    Pharmacopsychiatria; 1982 Sep; 15(5):156-60. PubMed ID: 7178230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.